JRJonathan Rabner

Jonathan Rabner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jonathan Rabner has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Alyssa LeBel

    Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, MA, USA

    4 shared publications
  • Philip C. Kendall

    4 shared publications
  • Alyssa Lebel

    Division of Pain Medicine, Department of Anesthesiology, Critical Care & Pain Medicine, Boston Children’s Hospital, Boston, MA 02115, USA

    3 shared publications
  • Laura E. Simons

    Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, United States

    3 shared publications
  • Lori Lazdowsky

    Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, USA

    3 shared publications
  • Alessandra Caruso

    Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, USA

    2 shared publications

Latest Publications

  • Open Access

    Children’s Literature on Anxiety: A Systematic Review and Content Analysis

    by Margaret Ellen Crane, Julia S. Ney, Katherine E. Holland, Jonathan Rabner, Marisa Meyer, Anthony J. Leon, Abigail M. Farina, Madison R. Brown, Philip C. Kendall

    Objective: Children’s literature can teach life lessons and effective coping strategies, and can be a way to disseminate evidence-based practices (EBPs) for mental health as a universal prevention strategy. We conducted a content analysis on the presence of EBPs for youth anxiety in children’s literature picture books about anxiety. Method: Analytic plan was preregistered on OSF. 1640 books were screened, and 191 books were coded for eight EBPs for youth anxiety: psychoeducation, labeling body sensations, relaxation, identifying/challenging anxious thoughts, problem solving, contingency management (e.g., rewards and praise), approaching-anxiety provoking situations (i.e., exposure), and post-approach processing.Results: Characters in the books modeled an average of 2.39 EBPs (SD = 1.76). The most frequently modeled EBPs were identifying/challenging anxious thoughts (60% of books), approaching-anxiety provoking situations (46%), and labeling body sensations (42%). The least commonly modeled EBP was contingency management (7%). Books written by licensed therapists were more likely to demonstrate post-approach processing. Books with self-help information at the end were more likely to model post-approach processing and relaxation skills. Books written for youth age 9-12 years modeled more EBPs than books written for youth age 8 years and younger.Conclusions: Children’s books on youth anxiety model relatively few EBPs. Although approaching anxiety-provoking situations was one of the most used EBPs, 54% of books with an anxious character do not model having that character face their fears–a key strategy for youth anxiety. Additionally, few books demonstrate use of rewards and praise by caregivers, who often read stories with their children. Clinicians, caregivers, and librarians are encouraged to purchase books written by therapists or with self-help information in the back, given that these books are more likely to model EBPs.


  • Open Access

    Cognitive Functioning in Youth with Anxiety Disorders: A Systematic Review

    by Jonathan C. Rabner, Julia S. Ney, Philip C. Kendall

    Anxiety disorders are disorders involving cognition. Research on cognition in youth with anxiety can focus on cognitive content (e.g., self-talk) as well cognitive functioning. The present review examines domains of cognitive functioning (i.e., episodic memory, language, attention, executive functioning, motor skills, and visual functioning) in youth diagnosed with an anxiety disorder. A database search of Embase, PsycINFO, and PubMed yielded 28 studies that met inclusion criteria of youth aged 17 years or younger, a sample diagnosed with a principal anxiety disorder and a comparison sample of controls, a comparison between those samples, and use of a behavioral measure of neuropsychological performance. Findings did not identify any cognitive functioning strengths for anxious youth. Deficits were found in two domains (i.e., receptive language and motor skills) whereas no deficits were found in attention, visuospatial skills and one domain of executive functioning (i.e., inhibition). Most domains had mixed findings. Additional analysis indicated that anxiety disorders in youth are not associated with diminished IQ. Directions for future research are identified including (a) the prioritization of studies with larger, representative samples (b) the role of cognitive functioning as a predictor of anxiety treatment outcome (c) the examination of the effect of treatment on cognitive performance, and (d) the course of anxiety and potential impairment in cognitive functioning.


  • Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long‐term Study (CAMELS)

    by Jonathan Rabner, Thomas M. Olino, Anne Marie Albano, Courtney P. Keeton, Dara Sakolsky, Boris Birmaher, John Piacentini, Tara S. Peris, Scott N. Compton, Elizabeth Gosch, et al.

    Background: Substance use problems and anxiety disorders are both highly prevalent and frequently cooccur in youth. The present study examined the benefits of successful anxiety treatment at 3–12 years after treatment completion on substance use outcomes (i.e. diagnoses and lifetime expected use). Methods: The sample was from the Child/Adolescent Anxiety Multimodal Extended Long‐term Study (CAMELS), a naturalistic follow‐up study to the Child/Adolescent Anxiety Multimodal Study (CAMS) which randomized youth to cognitive behavioral therapy (CBT; Coping cat ), medication (sertraline), their combination, or pill placebo. The first CAMELS visit occurred an average of 6.5 years following CAMS randomization. Participants were 319 youth (65.4% of the CAMS sample), aged 7–17 years at CAMS baseline assessment with a mean age of 17.6 years (range: 11–26 years) at the time of the first CAMELS follow‐up. Substance use outcomes included diagnoses as well as lifetime substance use (i.e. alcohol and tobacco use). Results: Eleven of 319 (3.4%) CAMELS participants were diagnosed with a substance use disorder at the initial follow‐up visit. When compared to the population lifetime rate of 11.4%, the rate of diagnoses in the posttreated sample was significantly lower. Additionally, rates of lifetime alcohol use were lower than population rates at the initial and final follow‐up visits. Rates of lifetime tobacco use were similarly lower than lifetime population rates at the initial visit (driven by significantly lower rates in the CBT treatment condition), but higher by the final visit. Furthermore, treatment remission (but not treatment response) was associated with a lower rate of substance use diagnoses at the initial follow‐up visit, although rates of lifetime alcohol and tobacco use did not differ by treatment outcome. Conclusions: Anxiety treatments confer a beneficial impact on problematic substance use (i.e. diagnoses) as well as on expected substance use (i.e. alcohol and tobacco use) for on average, a period of 6.5 years.


  • Impact of youth and caregiver worries about treatment on therapeutic process factors and posttreatment outcomes

    by Jonathan Rabner, Lesley A. Norris, Margaret E. Crane, Joshua Klugman, Philip C. Kendall

  • Do youth anxiety measures assess the same construct consistently throughout treatment? Results are...complicated

    by Jonathan C. Rabner, Thomas M. Olino, Anne Marie Albano, Golda S. Ginsburg, Scott N. Compton, John Piacentini, Dara Sakolsky, Boris Birmaher, Elizabeth Gosch, Philip C. Kendall

    Interventionists interpret changes in symptoms as reflecting response to treatment. However, changes in symptom functioning and the measurement of the underlying constructs may be reflected in reported change. Longitudinal measurement invariance (LMI) is a statistical approach that assesses the degree to which measures consistently capture the same construct over time. We examined LMI in measures of anxiety severity/symptoms [i.e., Pediatric Anxiety Rating Scale (PARS), Multidimensional Anxiety Scale for Children (MASC), Screen for Child Anxiety and Related Disorders (SCARED)] in anxious youth at baseline and posttreatment. Initial fit was inadequate for 27 of 38 baseline and posttreatment models, but model modifications resulted in acceptable fit. Tests of LMI supported scalar invariance for the PARS and many, but not all, MASC and SCARED subscales. Findings suggest that the PARS, and many MASC and SCARED subscales can accurately be used to measure change over time, however, others may reflect changes in measurement properties.


  • Differences in Pediatric Headache Prescription Patterns by Diagnosis

    by Jonathan Rabner, Allison Ludwick, Alyssa LeBel

    Few studies have reported prescription patterns for headache medication.


  • Pediatric Headache and Sleep Disturbance: A Comparison of Diagnostic Groups

    by Jonathan Rabner, Karen J. Kaczynski, Laura E. Simons, Alyssa LeBel

    Objective: To examine whether sleep disturbance differs by headache diagnosis in a pediatric sample, and whether this effect remains when other factors affecting sleep are included. Background: Primary headache disorders can be severe and disabling, impacting a child's functioning and quality of life. Many children and adolescents with chronic headaches also experience sleep difficulties, and there is likely a bidirectional relationship between headaches and sleep difficulties. Sleep problems may intensify functional and developmental difficulties in youth with chronic headaches. Despite this, research on sleep has largely been conducted only on those with migraines, with a dearth of studies including samples with tension‐type headache (TTH) or new daily persistent‐headache (NDPH). Methods: This retrospective chart review included 527 patients, ages 7‐17 years, with a primary headache diagnosis of migraine (n = 278), TTH (n = 157), and NDPH (n = 92). Patients completed measures of disability, anxiety, and depression and their parents completed measures of sleep disturbance. Results: Sleep disturbance was greater in patients with TTH (10.34 ± 5.94, P = .002) and NDPH (11.52 ± 6.40, P < .001) than migraine (8.31 ± 5.89). Across patient groups, greater sleep disturbance was significantly associated with higher levels of functional disability ( rs ≥ .16), anxiety ( rs ≥ .30), and depression ( rs ≥ .32). Additionally, higher pain levels were significantly associated with greater sleep disturbance among TTH patients ( r = .23), with this association non‐significant among the other headache groups. When simultaneously examining demographic, pain‐related, and emotional distress factors, older age, higher levels of disability and depression, and NDPH diagnosis were all significant predictors of greater sleep disturbance ( r 2 = .25). Conclusions: Assessment and treatment of sleep problems in pediatric patients with chronic headache is important with several contextual and headache diagnostic factors influencing the severity of sleep disturbance.


  • Open Access

    Rapid Screening of Risk in Pediatric Headache: Application of the Pediatric Pain Screening Tool

    by Lauren C. Heathcote, Jonathan Rabner, Alyssa Lebel, Jessica M. Hernandez, Laura E Simons

    The current study examined the application of a screening tool to identify biopsychosocial risk factors and derive prognostic risk groups in children and adolescents with headache pain. Youth (n = 242, 8–17 years, 75.6% female) presenting for evaluation at a tertiary pediatric headache clinic completed the nine-item Pediatric Pain Screening Tool (PPST) as well as measures of functional disability, pain catastrophizing, fear of pain, anxiety, and depressive symptoms. In addition, 119 patients reported on functional disability at 2-month follow-up. The PPST demonstrated discriminant validity that ranged from fair to good for identifying significant disability and high emotional distress. Receiver operating characteristic curve analyses indicated that established cutoff scores were appropriate for the current sample, and thus participants were classified into low-risk (21%), medium-risk (31%), and high-risk (48%) groups. Only 1–6% of patients who met reference standard case status for disability and emotional distress were classified as low risk, whereas 64–90% of patients who met reference standard case status were classified as high risk, suggesting robust stratification. The nine-item PPST may be a useful tool for efficiently identifying young patients with headache who are at risk of poor outcomes, and effectively classifying them into risk groups that could drive stratified treatment directly targeting patient needs.


  • The Sleep Hygiene Inventory for Pediatrics: Development and Validation of a New Measure of Sleep in a Sample of Children and Adolescents With Chronic Headache

    by Jonathan Rabner, Karen J. Kaczynski, Laura E. Simons, Alyssa A. Lebel

    Sleep plays a pivotal role in children and adolescents with headache. Although several sleep measures exist, no developed measures target the sleep issues common in pediatric patients with headache. The Sleep Hygiene Inventory for Pediatrics (SHIP) was developed for clinical purposes to fulfill this need. The aim of this study was to validate the SHIP for potential research applications in a sample of 1078 children and adolescents (7-17 years) with a primary headache diagnosis. Measure validation included assessments of internal consistency, construct validity, and criterion validity. The SHIP demonstrated strong internal consistency (Cronbach α = 0.84). The SHIP differentiated well between participants for whom sleep was and was not a clinical concern (P < .001; d =1.65), and was positively correlated with anxiety, depression, and disability. These analyses suggest that the SHIP is a psychometrically strong and valid assessment of sleep habits in pediatric patients with headache.